SIRT1 expression has been shown to be upregulated in a variety of CSCs both in vitro and in vivo, including glioma (Lee et al., 2015), breast (Ma et al., 2015), colorectal (Chen et al., 2014b), and leukemia (Li et al., 2012, 2014). Here, SIRT1 is linked to central nervous system cancer.